EUVIMEDEUVIMED entdecken
Crossref

Chlorogenic acid alleviates letrozole-induced polycystic ovary syndrome in mice by modulating inflammatory mediators and antioxidant signaling pathways

Seyed Sobhan Bahreiny, Layasadat Khorsandi, Khojasteh Hoseinynejad, Akram Ahangarpour

Journal of Reproductive Immunology · 2026

DOI: 10.1016/j.jri.2025.104805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2026. Verfasst von Seyed Sobhan Bahreiny und 3 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Persian Gulf Physiology Research Center, Medical Basic Sci…. Hauptthemen laut MEDLINE: Chlorogenic Acid, Polycystic Ovary Syndrome, Antioxidants, Ovary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Ahvaz Jondishapour University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a multifaceted endocrine disorder affecting 5-20 % of reproductive-aged women, characterized by hyperandrogenism, ovulatory dysfunction, insulin resistance, and chronic low-grade inflammation. This study investigates the therapeutic potential of chlorogenic acid (CGA), a bioactive polyphenol abundant with anti-inflammatory and antioxidant properties, in a letrozole (LZ)-induced PCOS mouse model. Forty-eight adult female mice were divided into four groups (n = 12): control, PCOS-induced (animals received daily oral administration of letrozole at 4 mg/kg/day for 21 days), PCOS-induced + CGA 50 mg/kg/day (PCOS-induced mice treated with chlorogenic acid at 50 mg/kg/day for 14 consecutive days), and PCOS-induced + CGA 100 mg/kg/day (PCOS-induced mice treated with chlorogenic acid at 100 mg/kg/day for 14 consecutive days). At the end of the experimental period, blood samples and ovarian tissues were collected from all groups for biochemical, molecular, and histopathological analyses. LZ-induced PCOS disrupted sex hormone profiles, causing hyperglycemia and elevated insulin resistance, alongside NLR family pyrin domain containing inflammasome (NLRP3) activation and nuclear factor erythroid 2-related factor 2 p65 (NF-κB p65) / Interleukin-1β (IL-1β) upregulation, driving chronic inflammation. Oxidative stress was evident through impaired Nrf2 activity, regulated by the Phosphoinositide 3-kinase (PI3K)/protein kinase B (PI3K/AKT) pathway. CGA treatment mitigated these pathological changes by enhancing ovarian Nrf2 mRNA expression, suppressing PI3K/AKT signaling, and attenuating inflammatory responses through downregulation of the NLRP3/NF-κB p65/IL-1β axis and pro-inflammatory cytokine production. CGA mitigates LZ-induced PCOS through the dual mechanism of modulating the PI3K/AKT-Nrf2 antioxidant defense mechanism and suppression of the NLRP3 inflammasome/NF-κB p65/IL-1β inflammatory pathway. DATA AVAILABILITY: The data supporting the findings of this study are available upon request from the corresponding author.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlorogenic AcidPolycystic Ovary SyndromeAntioxidantsOvaryAnti-Inflammatory AgentsAnimalsFemaleLetrozoleMiceSignal TransductionDisease Models, AnimalNLR Family, Pyrin Domain-Containing 3 ProteinInflammation MediatorsHumansOxidative StressNF-E2-Related Factor 2

Stichwörter der Autor:innen

Chlorogenic acid (CGA)InflammasomeLetrozolePolycystic ovarian syndrome

Substanzen

Chlorogenic AcidLetrozoleAntioxidantsNLR Family, Pyrin Domain-Containing 3 ProteinInflammation MediatorsNF-E2-Related Factor 2Nlrp3 protein, mouseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran; Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Scie…
  • Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: khorsandi.l@ajums.ac.ir.
  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: hoseinynejad.kh@ajums.ac.ir.
  • Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Electronic address: ahangarpur@ajums.ac.ir.

Förderung

  • Ahvaz Jondishapour University of Medical Sciences

Zitieren

APA

Bahreiny, S. S., Khorsandi, L., Hoseinynejad, K., & Ahangarpour, A. (2026). Chlorogenic acid alleviates letrozole-induced polycystic ovary syndrome in mice by modulating inflammatory mediators and antioxidant signaling pathways. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2025.104805

Vancouver

Bahreiny SS, Khorsandi L, Hoseinynejad K, Ahangarpour A. Chlorogenic acid alleviates letrozole-induced polycystic ovary syndrome in mice by modulating inflammatory mediators and antioxidant signaling pathways. Journal of Reproductive Immunology. 2026. doi:10.1016/j.jri.2025.104805

BibTeX
@article{Bahreiny2026,
  author = {Bahreiny, Seyed Sobhan and Khorsandi, Layasadat and Hoseinynejad, Khojasteh and Ahangarpour, Akram},
  title = {Chlorogenic acid alleviates letrozole-induced polycystic ovary syndrome in mice by modulating inflammatory mediators and antioxidant signaling pathways},
  journal = {Journal of Reproductive Immunology},
  year = {2026},
  doi = {10.1016/j.jri.2025.104805}
}
Kostenlos starten →